Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment—a retrospective cohort study

BACKGROUND: Human epidermal growth factor receptor-2 (HER-2) protein expression level could serve as a predictor of pathological complete response (pCR) to neoadjuvant trastuzumab-containing regimens. The aim of the present study was to evaluate whether pCR to neoadjuvant trastuzumab and pertuzumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiabin, Qiao, Jianghua, Ruan, Yuxia, Wang, Chengzheng, Li, Lianfang, Lu, Zhenduo, Sun, Xianfu, Zhang, Chongjian, Chen, Xiuchun, Yan, Min, Cui, Shude, Liu, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840990/
https://www.ncbi.nlm.nih.gov/pubmed/36654959
http://dx.doi.org/10.21037/gs-22-632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840990/
https://www.ncbi.nlm.nih.gov/pubmed/36654959
http://dx.doi.org/10.21037/gs-22-632

Ejemplares similares